Thus, ROCK2 dysregulation can affect the activity of IRF4, MYC, and RELA, three of the major transcriptional regulators implicated in ABC-DLBCL pathogenesis, indicating that ROCK2-dependent pathways can control the transcriptional landscape of these lymphomas by targeting multiple crucial regulatory hubs. This evidence concerns the gene ROCK2 and lymphoma.